| Name | Date Acquired | How Acquired | Date Sold | Purchaser Name | Gross Sales Price | Basis | Basis Method | Sales Expenses | Total (net) | Accumulated Depreciation |
|---|---|---|---|---|---|---|---|---|---|---|
| AMERICAN ENT ST NON COV | 2024-01 | PURCHASE | 2024-06 | 460,187 | 448,951 | 11,236 | ||||
| AMERICAN ENT LT NON COV | 2022-01 | PURCHASE | 2024-06 | 1,361,599 | 1,158,217 | 203,382 |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| AMERIPRISE INVESTMENTS | 11,978,428 | 13,735,680 |
| Description | Amount |
|---|---|
| BOOK/TAX | 8,393 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| EXPENSES | ||||
| BANK CHARGES | ||||
| OFFICE EXPENSE | 7,800 | 3,900 | 3,900 | |
| PAYROLL FEES | 2,451 | 1,225 | 1,226 | |
| ACCOUNTING FEES | 4,250 | 2,125 | 2,125 | |
| INVESTMENT EXPENSE | 21,656 | 21,656 |
| Description | Amount |
|---|---|
| BOOK/TAX | 5,701 |